2,366 research outputs found
Coming home to mother
No full textGift of Dr. Mary Jane Esplen.Piano vocal [instrumentation]We love to think of years ago [first line]We are coming home to Mother [first line of chorus]A flat [key]Piano [tempo]House, families, birds, photograph of M.E. Mollins [illustration]Popular song [form/genre]Publisher's advertisement on inside front [note]Mediatoon by G.A. Boyton [note
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia
No full textIntroduction: Hospital-acquired pneumonia is a common infection, associated with substantial mortality. Despite the increasing prevalence of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA), approved treatment options for this pathogen are limited. Areas covered: This article reviews the pharmacokinetics, dosing, preclinical studies and clinical efficacy, and safety of telavancin, with a particular focus on results from trials in nosocomial pneumonia. PubMed and Congress websites were searched for relevant articles published between 2003 and 2010. Expert opinion: Telavancin is a lipoglycopeptide antibiotic with rapid, bactericidal activity against MRSA, and may provide another option for the treatment of nosocomial pneumonia, owing to Gram-positive pathogens. © 2011 Informa UK, Ltd.American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P388, DOI DOI 10.1164-RCCM.200405-644ST; Andrews J, 2007, J ANTIMICROB CHEMOTH, V60, P677, DOI 10.1093-jac-dkm242; *AST PHARM INC, 2009, VIBATIV TEL INJ; Barcia-Macay M, 2008, J ANTIMICROB CHEMOTH, V61, P1288, DOI 10.1093-jac-dkn120; Barriere Steven, 2004, Journal of Clinical Pharmacology, V44, P689, DOI 10.1177-0091270004266620; Boselli E, 2005, CRIT CARE MED, V33, P1529, DOI 10.1097-01.CCM.0000168206.59873.80; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097-01.md.0000091184.93122.09; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128-AAC.46.5.1475-1480.2002; Corey GR, 2009, NAT REV DRUG DISCOV, V8, P929, DOI 10.1038-nrd3051; Corey GR, 2010, CLIN INFECT DIS, V51, P641, DOI 10.1086-655827; Cruciani M, 1996, J ANTIMICROB CHEMOTH, V38, P865; *CUB PHARM INC, 2010, CUB DAPT INJ PACK IN; Draghi DC, 2008, ANTIMICROB AGENTS CH, V52, P2383, DOI 10.1128-AAC.01641-07; Draghi DC, 2008, J ANTIMICROB CHEMOTH, V62, P116, DOI 10.1093-jac-dkn124; File TM, 2010, CLIN INFECT DIS, V51, P1395, DOI 10.1086-657313; Freire AT, 2010, DIAGN MICR INFEC DIS, V68, P140, DOI 10.1016-j.diagmicrobio.2010.05.012; Gander S, 2005, J ANTIMICROB CHEMOTH, V56, P337, DOI 10.1093-jac-dki198; Georges H, 1997, EUR J CLIN MICROBIOL, V16, P385, DOI 10.1007-BF01726369; Goldberg MR, 2010, PHARMACOTHERAPY, V30, P35, DOI 10.1592-phco.30.1.35; Goldberg MR, 2010, PHARMACOTHERAPY, V30, P806, DOI 10.1592-phco.30.8.806; Goldstein EJC, 2004, ANTIMICROB AGENTS CH, V48, P2149, DOI 10.1128-ACC.48.6.2149-2152.2004; Gonzalez C, 1999, CLIN INFECT DIS, V29, P1171, DOI 10.1086-313440; Gotfried MH, 2008, ANTIMICROB AGENTS CH, V52, P92, DOI 10.1128-AAC.00875-07; Gradelski E, 2001, INT J ANTIMICROB AG, V18, P43, DOI 10.1016-S0924-8579(01)00343-0; Hatano K, 2007, J ANTIBIOT, V60, P709; Hegde SS, 2004, ANTIMICROB AGENTS CH, V48, P3043, DOI 10.1128-AAC.48.8.3043-3050.2004; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001-archinte.166.19.2138; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128-AAC.49.3.1127-1134.2005; Honeybourne D, 2003, J ANTIMICROB CHEMOTH, V51, P1431, DOI 10.1093-jac-dkg262; Kalil AC, 2010, CRIT CARE MED, V38, P1802, DOI 10.1097-CCM.0b013e3181eb3b96; Kiem S, 2008, ANTIMICROB AGENTS CH, V52, P24, DOI 10.1128-AAC.00133-06; King A, 2004, J ANTIMICROB CHEMOTH, V53, P797, DOI 10.1093-jac-dkh156; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086-499367; Kollef MH, 1998, CHEST, V113, P412, DOI 10.1378-chest.113.2.412; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378-chest.128.6.3854; KUNKEL M, 2010, INF DIS SOC AM 48 AN; LAMER C, 1993, ANTIMICROB AGENTS CH, V37, P281; Leadbetter MR, 2004, J ANTIBIOT, V57, P326; Leonard SN, 2008, PHARMACOTHERAPY, V28, P458, DOI 10.1592-phco.28.4.458; Leuthner KD, 2006, J ANTIMICROB CHEMOTH, V58, P338, DOI 10.1093-jac-dkl235; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086-491709; Liu C, 2011, CLIN INFECT DIS, V52, pE18, DOI 10.1093-cid-ciq146; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128-AAC.00113-08; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3731, DOI 10.1128-AAC.00101-07; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P2300, DOI 10.1128-AAC.01110-07; Lodise TP, 2009, CLIN INFECT DIS, V49, P507, DOI 10.1086-600884; Luna CM, 1997, CHEST, V111, P676, DOI 10.1378-chest.111.3.676; Lunde CS, 2009, ANTIMICROB AGENTS CH, V53, P3375, DOI 10.1128-AAC.01710-08; Madrigal AG, 2005, ANTIMICROB AGENTS CH, V49, P3163, DOI 10.1128-AAC.49.8.3163-3165.2005; Mendes RE, 2010, INT J ANTIMICROB AG, V36, P374, DOI 10.1016-j.ijantimicag.2010.05.016; Mimoz O, 2006, INTENS CARE MED, V32, P775, DOI 10.1007-s00134-006-0136-3; Nannini EC, 2008, EXPERT OPIN PHARMACO, V9, P2197, DOI 10.1517-14656566.9.12.2197 ; Nguyen HA, 2009, ANTIMICROB AGENTS CH, V53, P1434, DOI 10.1128-AAC.01145-08; Odenholt I, 2007, ANTIMICROB AGENTS CH, V51, P3311, DOI 10.1128-AAC.01470-06; Pace JL, 2003, ANTIMICROB AGENTS CH, V47, P3602, DOI 10.1128-AAC.47.11.3602-3604.2003; Pertel PE, 2008, CLIN INFECT DIS, V46, P1142, DOI 10.1086-533441; Pfaller MA, 2010, J ANTIMICROB CHEMOTH, V65, P2396, DOI 10.1093-jac-dkq335; *PFIZ INC, 2010, ZYVOX LIN INJ LIN TA; Powers JH, 2004, CHEST, V126, P314, DOI 10.1378-chest.126.1.314; Putnam SD, 2010, DIAGN MICR INFEC DIS, V67, P359, DOI 10.1016-j.diagmicrobio.2010.03.009; Reyes N, 2006, J ANTIMICROB CHEMOTH, V58, P462, DOI 10.1093-jac-dkl222; Reyes N, 2005, ANTIMICROB AGENTS CH, V49, P4344, DOI 10.1128-AAC.49.10.4344-4346.2005; Rodvold KA, 2009, ANTIMICROB AGENTS CH, V53, P3294, DOI 10.1128-AAC.00144-09; Rotstein C, 2008, CAN J INFECT DIS MED, V19, P19; Rubinstein E, 2011, CLIN INFECT DIS, V52, P31, DOI 10.1093-cid-ciq031; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086-491712; Sader HS, 2009, ANTIMICROB AGENTS CH, V53, P4127, DOI 10.1128-AAC.00616-09; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097-01.CCM.0000181731.53912.D9; Saravolatz LD, 2007, J ANTIMICROB CHEMOTH, V60, P406, DOI 10.1093-jac-dkm211; Shaw JP, 2010, ANTIMICROB AGENTS CH, V54, P3365, DOI 10.1128-AAC.01750-09; Shaw JP, 2005, ANTIMICROB AGENTS CH, V49, P195, DOI 10.1128-AAC.49.1.195-201.2005; Silverman JA, 2005, J INFECT DIS, V191, P2149, DOI 10.1086-430352; Sivagnanam S, 2003, CRIT CARE, V7, P119, DOI 10.1186-cc1871; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086-524667; Steinkraus G, 2007, J ANTIMICROB CHEMOTH, V60, P788, DOI 10.1093-jac-dkm258; Stryjewski ME, 2006, ANTIMICROB AGENTS CH, V50, P862, DOI 10.1128-AAC.50.3.862-867.2006; Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086-510386; Stryjewski ME, 2008, CLIN INFECT DIS, V46, P1683, DOI 10.1086-587896; Stryjewski ME, 2005, CLIN INFECT DIS, V40, P1601, DOI 10.1086-429914; Stucki A, 2006, ANTIMICROB AGENTS CH, V50, P770, DOI 10.1128-AAC.50.2.770-773.2006; Sun HK, 2006, ANTIMICROB AGENTS CH, V50, P788, DOI 10.1128-AAC.50.2.788-790.2006; Tice AD, 2003, J ANTIMICROB CHEMOTH, V51, P1261, DOI 10.1093-jac-dkg186; Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007-s00134-008-1336-9; Tsuji BT, 2008, DIAGN MICR INFEC DIS, V60, P441, DOI 10.1016-j.diagmicrobio.2007.11.011; Wang GQ, 2006, J CLIN MICROBIOL, V44, P3883, DOI 10.1128-JCM.01388-06; Wong SL, 2010, PHARMACOTHERAPY, V30, P136, DOI 10.1592-phco.30.2.136; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378-chest.124.5.1789; *WYETH PHARM INC, 2010, TYGACIL TIG FOR INJ; 2009, DA 22 110 VIBATIV TE55
M.E. Church exterior
No full textA monochrome postcard of the M.E. Church in Georgetown, Delaware. The church was made out of brick and had a tall tower on its corner. Writing on the right indicates that the author was having a good time. Mrs. P. H. Adkins of Milton, Delaware, received this postcard. A postmark on the back indicates that this postcard was mailed from Georgetown, Delaware. The postage stamp is a one-cent U.S. #300, Benjamin Franklin. The back of the postcard is labeled 75.00 and 0240
M.E. Church exterior
No full textA monochrome postcard of the M.E. Church in Georgetown, Delaware. The church was made out of brick and had a tall tower on its corner. Writing on the right indicates that the author was having a good time. Mrs. P. H. Adkins of Milton, Delaware, received this postcard. A postmark on the back indicates that this postcard was mailed from Georgetown, Delaware. The postage stamp is a one-cent U.S. #300, Benjamin Franklin. The back of the postcard is labeled 75.00 and 0240
On using Directional Information for Parameter Space Decomposition in Ellipse Detection
No full textIn this paper we use the parametric polar representation to extend the application of edge directional information from circle to ellipse extraction. As a result we obtain a mapping which decomposes the parameter space required for ellipse extraction into two independent sub-spaces and one final histogram accumulator. The mapping includes the tangent of the angle of the first and second directional derivatives. These tangents are computed by considering edge direction at two border points. We show that the use of gradient information for parameter space decomposition avoids the intensive point labelling imposed by geometric constraints used by other approaches
La fecondazione assistita dopo dieci anni di legge 40 : il punto di vista del costituzionalista
No full textThe Author of this paper adds the point of view of the constitutionalist to the debate on the Italian statute n.40/1994 on assisted reproduction illustrated by Flamigni and Mori in their work. The paper ends with a reflection on the recent decision n. 162/2014 issued by the Constitutional Court, which has declared the illegitimacy of the prohibition of heterologous reproduction
L'approvazione della legge Cirinnà : fra riconoscimento dei diritti e scontro ideologico
No full textThe New Italian Law on Civil Unions: Between Rights Recognition and Ideological Clash Abstract: The author examines the coming into force of the first Italian law on civil unions, which, for the first time, grants protection for both homosexual and different sex couples
La Corte costituzionale chiude la porta agli scienziati in nome della dignità dell’embrione
No full textThis essay aims to analize decision no. 84 of 2016 of the Italian Constitu-tional Court, on the matter of scientific research on embryos.
In particular the essay dwells with the problematic acknowledgement of the embryo dignity. The Author considers this aspect in the context of the relation between sci-entific evolution and legislative discretionality, taking into account the other deci-sions of the Court on the matter of medically assisted procreation
Laicità costituzionale e fondamentalismi tra Italia ed Europa : considerazioni a partire da alcune decisioni giurisprudenziali
No full textAttraverso un’analisi della giurisprudenza, italiana ed europea, l’autrice ragiona sul tema del rapporto tra laicità costituzionale, fondamentalismi religiosi e tutela dei diritti individuali nell’ambito della società multiculturale.
Il saggio prende le mosse dalla nozione di laicità, nella sua duplice accezione positiva e negativa, per poi affrontare l’esame della giurisprudenza a partire da una ricostruzione dell’approccio dei giudici nei confronti dei reati “culturalmente motivati” e, più in generale, dell’ingresso e del ruolo dei simboli religiosi nello spazio pubblico.
Il saggio intende, quindi, mettere in luce le pericolose ricadute che un’apertura indistinta all’istituto della giustificazione culturale e religiosa può provocare sulla tenuta costituzionale dei diritti fondamentali della persona.Throughout an investigation of the most significant national and european case-law, the author chooses to focus on the connection among constitutional secularity, fundamentalism and individual rights protection within multicultural societies.
The article starts with the dual concept of constitutional secularity, positive and negative, and goes on by addressing case-law’s approach to cultural offences and to the role and purpose of religious symbols in public spaces.
Therefore, the article aims at highlighting the risks involved in the tolerance of any form of cultural defense when it comes to the protection of fundamental rights
Helical mode interactions and spectral energy transfer in magnetohydrodynamic turbulence
No full textSpectral transfer processes in magnetohydrodynamic (MHD) turbulence are investigated by decomposition of the velocity and magnetic fields in Fourier space into helical modes. In 1992, Waleffe (Phys. Fluids A, 4:350 (1992)) used this decomposition to calculate triad interactions for isotropic hydrodynamic turbulence and determined whether a given triad contributed to forward or reverse energy transfer depending on the helicities of the interacting modes. The problem becomes more difficult in MHD due to the need to treat a coupled system of partial differential equations and the energy transfers between the magnetic and velocity fields. This requires the development of techniques that extend Waleffe's work, which are subsequently used to calculate the direction of energy transfer processes originating from triad interactions derived from the MHD equations. In order to illustrate the possible transfer processes that arise from helical mode interactions, we focus on simplified cases and putting special emphasis on interactions resulting in reverse spectral energy transfer. This approach also proves to be helpful in determining the nature of certain energy transfer processes, where transfer of energy between different fields and between the same field can be distinguished. Reverse transfer of magnetic energy was found if the helicities of two modes corresponding to the smaller wavenumbers are the same, while for reverse transfer of kinetic energy Waleffe's result is recovered. Reverse transfer of kinetic to magnetic energy is facilitated if the interacting magnetic field modes are of opposite helicity, and no reverse transfer of magnetic to kinetic energy was found. More generally, the direction of energy transfer not only depends on helicity but also on the ratio of magnetic to kinetic energy. For the magnetically dominated case reverse transfer occurs of all helicities are the same, the kinetically dominated case two modes need to have the same helicity while the third mode is of opposite helicity to allow reverse transfer
- …
